Skip to content
10-Q

Quarterly Report

Mirum Pharmaceuticals, Inc. MIRM

0001759425-25-000054

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 51.39M sh
Shares Diluted Q3 2025 · Sep 30, 2025 56.99M sh
Shares Diluted Q3 2025 · Sep 30, 2025 49.76M sh
Shares Diluted Q3 2025 · Sep 30, 2024 47.78M sh
Shares Diluted Q3 2025 · Sep 30, 2024 47.32M sh
Capex Q3 2025 · Sep 30, 2025 $354K
Capex Q3 2025 · Sep 30, 2024 $973K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $49.76M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $15.39M
Short Term Investments Q3 2025 · Sep 30, 2025 $93.53M
Short Term Investments Q3 2025 · Dec 31, 2024 $57.81M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $282.02M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $222.5M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $222.97M
Stockholders Equity Q3 2025 · Sep 30, 2025 $292.05M
Stockholders Equity Q3 2025 · Jun 30, 2025 $255.16M
Stockholders Equity Q3 2025 · Mar 31, 2025 $233.26M
Stockholders Equity Q3 2025 · Dec 31, 2024 $225.64M
Stockholders Equity Q3 2025 · Sep 30, 2024 $232.02M
Stockholders Equity Q3 2025 · Jun 30, 2024 $228.99M
Stockholders Equity Q3 2025 · Mar 31, 2024 $234.6M
Stockholders Equity Q3 2025 · Dec 31, 2023 $248.67M
Current Liabilities Q3 2025 · Sep 30, 2025 $160.36M
Current Liabilities Q3 2025 · Dec 31, 2024 $126.55M
Total Liabilities Q3 2025 · Sep 30, 2025 $493.07M
Total Liabilities Q3 2025 · Dec 31, 2024 $445.11M
Current Assets Q3 2025 · Sep 30, 2025 $530.58M
Current Assets Q3 2025 · Dec 31, 2024 $392.79M
Total Assets Q3 2025 · Sep 30, 2025 $785.12M
Total Assets Q3 2025 · Dec 31, 2024 $670.75M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.05
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.30
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.36
Eps Basic Q3 2025 · Sep 30, 2025 $0.06
Eps Basic Q3 2025 · Sep 30, 2025 −$0.35
Eps Basic Q3 2025 · Sep 30, 2024 −$0.30
Eps Basic Q3 2025 · Sep 30, 2024 −$1.36
Sga Expense Q3 2025 · Sep 30, 2025 $61.91M
Sga Expense Q3 2025 · Sep 30, 2025 $182.9M
Sga Expense Q3 2025 · Sep 30, 2024 $50.55M
Sga Expense Q3 2025 · Sep 30, 2024 $145.39M
Net Income Q3 2025 · Sep 30, 2025 $2.91M
Net Income Q3 2025 · Sep 30, 2025 −$17.63M
Net Income Q3 2025 · Jun 30, 2025 −$5.86M
Net Income Q3 2025 · Mar 31, 2025 −$14.68M
Net Income Q3 2025 · Sep 30, 2024 −$14.24M
Net Income Q3 2025 · Sep 30, 2024 −$64.15M
Net Income Q3 2025 · Jun 30, 2024 −$24.64M
Net Income Q3 2025 · Mar 31, 2024 −$25.28M
Operating Income Q3 2025 · Sep 30, 2025 $2.6M
Operating Income Q3 2025 · Sep 30, 2025 −$17.57M
Operating Income Q3 2025 · Sep 30, 2024 −$12.68M
Operating Income Q3 2025 · Sep 30, 2024 −$63.38M
Revenue Q3 2025 · Sep 30, 2025 $133.01M
Revenue Q3 2025 · Sep 30, 2025 $372.38M
Revenue Q3 2025 · Sep 30, 2024 $90.38M
Revenue Q3 2025 · Sep 30, 2024 $237.47M